FYI ... Nivolumab was my Clinical Trial therapy in 2014😲🤔👍💪
The U.S. FDA has approved nivolumqb plus ipilimumab for dMMR / MSI-H metastatic colorectal cancer. GCCA President, Nicole Sheahan, commented, “Colorectal...
The U.S. FDA has approved nivolumqb plus ipilimumab for dMMR / MSI-H metastatic ...